Pneumonitis in Patients Receiving Thoracic Radiotherapy and Osimertinib: A Multi-Institutional Study

INTRODUCTION: Thoracic radiotherapy (TRT) is increasingly used in patients receiving osimertinib for advanced NSCLC, and the risk of pneumonitis is not established. We investigated the risk of pneumonitis and potential risk factors in this population. METHODS: We performed a multi-institutional retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Banla, Leou Ismael, Tzeng, Alice, Baillieul, John P., Kandekhar, Melin J., Fitzgerald, Kelly J., LoPiccolo, Jaclyn, Poitras, Holly A., Soto, Daniel E., Rotow, Julia K., Singer, Lisa, Willers, Henning, Kozono, David E., Janne, Pasi A., Mak, Raymond H., Piotrowska, Zofia, Keane, Florence K., Kann, Benjamin H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507641/
https://www.ncbi.nlm.nih.gov/pubmed/37732171
http://dx.doi.org/10.1016/j.jtocrr.2023.100559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507641/
https://www.ncbi.nlm.nih.gov/pubmed/37732171
http://dx.doi.org/10.1016/j.jtocrr.2023.100559

Ejemplares similares